Prosecution Insights
Last updated: April 19, 2026

Arbor Biotechnologies, Inc.

5 pending office actions

Portfolio Summary

5
Total Pending OAs
2
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18356822 COMPOSITIONS COMPRISING A VARIANT POLYPEPTIDE AND USES THEREOF MOAZZAMI, NAGHMEH NINA 1652 Non-Final OA Jul 21, 2023
16626932 NOVEL CRISPR RNA TARGETING ENZYMES AND SYSTEMS AND USES THEREOF LEITH, NANCY J 1636 Non-Final OA Mar 17, 2023
17931027 COMPOSITIONS COMPRISING A CAS12I POLYPEPTIDE AND USES THEREOF MCLEOD, AFRICA MHAIRIE 1635 Final Rejection Sep 09, 2022
17830212 GENE EDITING SYSTEMS COMPRISING A CRISPR NUCLEASE AND USES THEREOF LIPPOLIS, ALEXANDRA ROSE 1637 Final Rejection Jun 01, 2022
17497725 NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMS DACE DENITO, ALEXANDRA GERALDINE 1636 Non-Final OA Oct 08, 2021

Managing Arbor Biotechnologies, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month